Zeus Capital Director of Healthcare Research Dr Gary Waanders caught up with DirectorsTalk for an exclusive interview to discuss Oncimmune Holdings PLC (LON:ONC) Q1: This morning Oncimmune released its..
Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the..
Oncimmune Holdings plc (LON:ONC), a pioneering UK-based biotech developing and commercialising blood tests for early cancer detection, today released its Interim results for the 6 months to November 30, 2016..
